Search
for
Sort by
Research 151–180 of 1000+
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- The JAK/STAT signaling pathway: from bench to clinic
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Current and future pharmacotherapy for alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Alopecia Areata and Alopecia Areata Incognita
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Pharmacotherapy of alopecia areata
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Research Progress on the Application of Stem Cells in Hair Regeneration
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Free Papers Medical and Surgical: Hair and Nails
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients